The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3

被引:133
作者
Li, Y
Inoki, K
Vacratsis, P
Guan, KL
机构
[1] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1074/jbc.M300862200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tuberous sclerosis complex (TSC) is a genetic disease caused by mutations in either TSC1 or TSC2 tumor suppressor genes. TSC1 and TSC2 (also known as hamartin and tuberin, respectively) form a functional complex and negatively regulate cell growth by inhibiting protein synthesis. 14-3-3 binds to TSC2 and may inhibit TSC2 function. We have reported previously that phosphorylation of serine 1210 (Ser(1210)) in TSC2 is essential for 14-3-3 binding. Here we show that serum and anisomycin enhance the interaction between TSC2 and 14-3-3 by stimulating phosphorylation of Ser(1210). Activation of p38 MAP kinase (p38) is essential for the stimulating effect of serum and anisomycin although p38 is not directly responsible for the phosphorylation of Ser(1210) in TSC2. Both in vitro and in vivo experiments demonstrate that the p38-activated kinase MK2 (also known as MAP-KAPK2) is directly responsible for the phosphorylation of Ser(1210). Our data show that anisomycin stimulates phosphorylation of Ser(1210) of TSC2 via the p38-MK2 kinase cascade. Phosphorylation of TSC2 by MK2 creates a 14-3-3 binding site and thus regulates the cellular function of the TSC2 tumor suppressor protein.
引用
收藏
页码:13663 / 13671
页数:9
相关论文
共 45 条
[1]   Tuberin phosphorylation regulates its interaction with hamartin - Two proteins involved in tuberous sclerosis [J].
Aicher, LD ;
Campbell, JS ;
Yeung, RS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) :21017-21021
[2]   Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration [J].
Astrinidis, A ;
Cash, TP ;
Hunter, DS ;
Walker, CL ;
Chernoff, J ;
Henske, EP .
ONCOGENE, 2002, 21 (55) :8470-8476
[3]   Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients [J].
Au, KS ;
Rodriguez, JA ;
Finch, JL ;
Volcik, KA ;
Roach, ES ;
Delgado, MR ;
Rodriguez, E ;
Northrup, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (02) :286-294
[4]   PKB binding proteins: Getting in on the akt [J].
Brazil, DP ;
Park, J ;
Hemmings, BA .
CELL, 2002, 111 (03) :293-303
[5]   PARALLEL SIGNAL-PROCESSING AMONG MAMMALIAN MAPKS [J].
CANO, E ;
MAHADEVAN, LC .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (03) :117-122
[6]   RETRACTED: Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin (Retracted Article) [J].
Dan, HC ;
Sun, M ;
Yang, L ;
Feldman, RI ;
Sui, XM ;
Ou, CC ;
Nellist, M ;
Yeung, RS ;
Halley, DJJ ;
Nicosia, SV ;
Pledger, WJ ;
Cheng, JQ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) :35364-35370
[7]   Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6 [J].
Enslen, H ;
Raingeaud, J ;
Davis, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) :1741-1748
[8]   Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling [J].
Gao, XS ;
Zhang, Y ;
Arrazola, P ;
Hino, O ;
Kobayashi, T ;
Yeung, RS ;
Ru, BG ;
Pan, DJ .
NATURE CELL BIOLOGY, 2002, 4 (09) :699-704
[9]   TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth [J].
Gao, XS ;
Pan, DJ .
GENES & DEVELOPMENT, 2001, 15 (11) :1383-1392
[10]  
GOMEZ MR, 1991, ANN NY ACAD SCI, V615, P1